A new study revealed that adaptive changes in Pseudomonas aeruginosa may exacerbate pulmonary inflammation and contribute to the pathogenesis and progression of chronic…
Ana Pamplona, PhD
Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pamplona, PhD
A new study entitled “A novel siderophore system is essential for the growth of Pseudomonas aeruginosa in airway mucus”…
Concert Pharmaceuticals will present data from a Phase 1 single ascending dose trial of experimental CF therapy CTP-656, a next…
Intravenous Antibiotic Therapy Found To Improve General Quality of Life of Cystic Fibrosis Patients
A new study on the association between proteases and anti-proteases during Cystic fibrosis entitled “Changes of Proteases,…
A new study revealed that microRNA16 — a small non-coding RNA genes that regulates gene expression — can…
A new study on the clinical outcomes of cystic fibrosis revealed that patients infected only by Staphylococcus aureus infection in the absence…
New Research Into Bacterial Behavior Could Aid in Mitigating Antibiotic Resistance in CF Patients
Researchers from The University of Texas at Austin recently revealed that the pathogenic…
During the American Thoracic Society 2015 International Conference being held in Denver, Colorado, 15-20 of May, researchers from Oregon…
Researchers have discovered an association between Cystic Fibrosis and infection with the parasite Toxoplasma gondii. The study entitled “…
A new clinical study showed that AffloVest®, portable High Frequency Chest Wall Oscillation (HFCWO) vest, improved lung function scores…